Global Microphysiological System Supply, Demand and Key Producers, 2026-2032
The global Microphysiological System market size is expected to reach $ 725 million by 2032, rising at a market growth of 15.8% CAGR during the forecast period (2026-2032).
Microphysiological Systems (MPS) are advanced in vitro models that use human-derived cells, tissues, or organoids together with technologies such as three-dimensional culture, microfluidics, extracellular matrices, dynamic perfusion, mechanical stimulation, and integrated sensing to reproduce key structural, functional, and physiological characteristics of human tissues or organs. MPS include Organ-on-Chip systems, multi-organ platforms, organoid-based MPS, and certain engineered 3D tissue models. These systems can simulate cell-cell interactions, tissue barriers, fluid shear stress, and inter-organ communication. They are mainly used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing, with the goal of improving the human relevance and predictive value of preclinical research.Microphysiological Systems (MPS) vary significantly in price depending on platform format, cell source, tissue model complexity, throughput, and the level of integration with perfusion, imaging, and automation. In 2025–2026, basic MPS chips or 3D culture consumables are generally priced at around US$50–1,000 per chip or plate, while complex human cell-based or organoid model kits typically range from US$500–5,000 per kit. Platforms equipped with pumping, perfusion, or culture-control functions generally cost about US$5,000–30,000 per system, while high-throughput automated MPS workstations may reach US$50,000–150,000 or more per system.
The upstream value chain mainly includes human primary cells, induced pluripotent stem cells, organoids, culture media, extracellular matrices, hydrogels, PDMS, COC/COP, glass, porous membranes, sensors, and microfluidic components. Midstream companies develop and integrate MPS chips, 3D tissue models, perfusion-control devices, and automated platforms. Downstream users mainly include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, and regulatory agencies. MPS platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.
Regulatory agencies are increasingly encouraging the use of New Approach Methodologies, including microphysiological systems, organ-on-chip platforms, organoids, and computational models. In April 2025, the FDA released a roadmap to reduce reliance on animal testing in preclinical safety studies and specifically highlighted human-based models such as organ-on-chip systems. This regulatory shift is strengthening demand for validated MPS platforms in pharmaceutical safety and efficacy assessment.
Increasing Demand for Human-Relevant Preclinical Models
Traditional 2D cell cultures often fail to reproduce complex tissue architecture and physiological functions, while animal models may show species-specific differences in metabolism, immune response, and drug toxicity. MPS platforms recreate important biochemical, mechanical, and physiological conditions using human-derived cells and tissues, improving their potential to predict human drug responses and supporting broader adoption in drug discovery and development.
Rising Pharmaceutical R&D Efficiency Requirements
Pharmaceutical and biotechnology companies are seeking technologies that can identify ineffective or toxic candidates earlier in development. MPS platforms can support drug screening, ADME/DMPK studies, toxicity testing, disease modeling, and efficacy assessment using physiologically relevant human models. NIH continues to support tissue-chip programs designed to improve predictions of drug safety and toxicity in humans, strengthening the technology’s position within preclinical research workflows.
Market Restraints
High Platform and Experimental Costs
MPS experiments may require specialized chips or culture plates, human primary or stem-cell-derived cells, extracellular matrices, sensors, perfusion equipment, imaging systems, and dedicated analytical workflows. These requirements make MPS studies more expensive and operationally demanding than conventional 2D cell culture, particularly for small biotechnology companies and academic laboratories with limited budgets.
Insufficient Standardization and Reproducibility
Commercial MPS platforms differ substantially in materials, channel architecture, cell sources, extracellular matrices, flow conditions, assay endpoints, and operating protocols. This heterogeneity can create challenges in comparing results between laboratories and platforms. Wider regulatory and pharmaceutical adoption therefore requires improved quality control, reproducibility, standardized reporting, and fit-for-purpose validation criteria. OECD guidance increasingly emphasizes quality-management and fit-for-purpose considerations for MPS-related regulatory data.
Dependence on High-Quality Human Cells and Biological Materials
MPS performance is highly dependent on primary human cells, induced pluripotent stem-cell-derived cells, organoids, culture media, and extracellular matrices. Variability between donors and production batches, limited availability of certain mature cell types, and difficulties maintaining stable phenotypes during long-term culture can reduce reproducibility and complicate large-scale deployment. Market Opportunities
Expansion into Regulatory Toxicology and Safety Assessment
One of the largest opportunities for MPS is its transition from an academic research tool to a qualified platform for regulatory and industrial safety assessment. Liver, cardiac, kidney, lung, immune, and barrier models have particular potential for evaluating organ-specific toxicity. FDA and NIH collaboration on New Approach Methodologies is creating a more favorable environment for validated human-based models to enter formal drug-development workflows.
Development of High-Throughput and Automated MPS Platforms
Integration with multi-well formats, automated liquid handling, high-content imaging, biosensors, and data-analysis software can substantially increase MPS throughput and reproducibility. The industry is moving beyond manually operated individual chips toward scalable platforms capable of running dozens or hundreds of tissue models simultaneously, making MPS more compatible with pharmaceutical screening workflows and increasing recurring demand for consumables.
Integration with Organoids, iPSC Technology and AI
Combining MPS with patient-derived organoids, induced pluripotent stem cells, gene editing, and artificial intelligence can enable more disease-specific and patient-specific models. Such platforms could support precision medicine, patient stratification, rare-disease research, and prediction of individual drug responses. Multi-organ MPS further creates opportunities for studying systemic pharmacology, PK/PD relationships, metabolism, and organ-to-organ interactions.
Market Challenges
Balancing Physiological Complexity with Throughput and Scalability
Increasing biological realism often requires multiple cell types, vascular interfaces, extracellular matrices, mechanical stimulation, dynamic perfusion, and real-time sensing. However, greater complexity usually increases operating difficulty, cost, variability, and assay duration. Achieving sufficient physiological relevance while maintaining reproducibility, throughput, automation, and commercial scalability remains a fundamental technical challenge.
Extensive Validation Required for Regulatory Acceptance
Regulatory interest in MPS is increasing, but formal use in decision-making requires robust evidence demonstrating reproducibility, reliability, defined applicability domains, and correlation with human clinical outcomes. Cross-laboratory studies, reference-compound testing, standardized protocols, and comparison against existing methods remain necessary before individual MPS models can achieve broad regulatory acceptance.
Fragmentation of Technologies and Commercial Platforms
The MPS market includes organ-on-chip systems, organoid-based models, engineered 3D tissues, membrane and membrane-free platforms, passive and pump-driven systems, and single- and multi-organ configurations. No single architecture has emerged as the universal industry standard. This fragmentation increases platform-selection risks for pharmaceutical companies and creates significant R&D and commercialization challenges for MPS suppliers.
This report is a detailed and comprehensive analysis of the world market for Microphysiological System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Microphysiological System that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Microphysiological System market
2. What is the demand of the global Microphysiological System market?
3. What is the year over year growth of the global Microphysiological System market?
4. What is the total value of the global Microphysiological System market?
5. Who are the Major Players in the global Microphysiological System market?
6. What are the growth factors driving the market demand?
Microphysiological Systems (MPS) are advanced in vitro models that use human-derived cells, tissues, or organoids together with technologies such as three-dimensional culture, microfluidics, extracellular matrices, dynamic perfusion, mechanical stimulation, and integrated sensing to reproduce key structural, functional, and physiological characteristics of human tissues or organs. MPS include Organ-on-Chip systems, multi-organ platforms, organoid-based MPS, and certain engineered 3D tissue models. These systems can simulate cell-cell interactions, tissue barriers, fluid shear stress, and inter-organ communication. They are mainly used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing, with the goal of improving the human relevance and predictive value of preclinical research.Microphysiological Systems (MPS) vary significantly in price depending on platform format, cell source, tissue model complexity, throughput, and the level of integration with perfusion, imaging, and automation. In 2025–2026, basic MPS chips or 3D culture consumables are generally priced at around US$50–1,000 per chip or plate, while complex human cell-based or organoid model kits typically range from US$500–5,000 per kit. Platforms equipped with pumping, perfusion, or culture-control functions generally cost about US$5,000–30,000 per system, while high-throughput automated MPS workstations may reach US$50,000–150,000 or more per system.
The upstream value chain mainly includes human primary cells, induced pluripotent stem cells, organoids, culture media, extracellular matrices, hydrogels, PDMS, COC/COP, glass, porous membranes, sensors, and microfluidic components. Midstream companies develop and integrate MPS chips, 3D tissue models, perfusion-control devices, and automated platforms. Downstream users mainly include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, and regulatory agencies. MPS platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.
Market Drivers
Growing Regulatory Support for Non-Animal Testing MethodsRegulatory agencies are increasingly encouraging the use of New Approach Methodologies, including microphysiological systems, organ-on-chip platforms, organoids, and computational models. In April 2025, the FDA released a roadmap to reduce reliance on animal testing in preclinical safety studies and specifically highlighted human-based models such as organ-on-chip systems. This regulatory shift is strengthening demand for validated MPS platforms in pharmaceutical safety and efficacy assessment.
Increasing Demand for Human-Relevant Preclinical Models
Traditional 2D cell cultures often fail to reproduce complex tissue architecture and physiological functions, while animal models may show species-specific differences in metabolism, immune response, and drug toxicity. MPS platforms recreate important biochemical, mechanical, and physiological conditions using human-derived cells and tissues, improving their potential to predict human drug responses and supporting broader adoption in drug discovery and development.
Rising Pharmaceutical R&D Efficiency Requirements
Pharmaceutical and biotechnology companies are seeking technologies that can identify ineffective or toxic candidates earlier in development. MPS platforms can support drug screening, ADME/DMPK studies, toxicity testing, disease modeling, and efficacy assessment using physiologically relevant human models. NIH continues to support tissue-chip programs designed to improve predictions of drug safety and toxicity in humans, strengthening the technology’s position within preclinical research workflows.
Market Restraints
High Platform and Experimental Costs
MPS experiments may require specialized chips or culture plates, human primary or stem-cell-derived cells, extracellular matrices, sensors, perfusion equipment, imaging systems, and dedicated analytical workflows. These requirements make MPS studies more expensive and operationally demanding than conventional 2D cell culture, particularly for small biotechnology companies and academic laboratories with limited budgets.
Insufficient Standardization and Reproducibility
Commercial MPS platforms differ substantially in materials, channel architecture, cell sources, extracellular matrices, flow conditions, assay endpoints, and operating protocols. This heterogeneity can create challenges in comparing results between laboratories and platforms. Wider regulatory and pharmaceutical adoption therefore requires improved quality control, reproducibility, standardized reporting, and fit-for-purpose validation criteria. OECD guidance increasingly emphasizes quality-management and fit-for-purpose considerations for MPS-related regulatory data.
Dependence on High-Quality Human Cells and Biological Materials
MPS performance is highly dependent on primary human cells, induced pluripotent stem-cell-derived cells, organoids, culture media, and extracellular matrices. Variability between donors and production batches, limited availability of certain mature cell types, and difficulties maintaining stable phenotypes during long-term culture can reduce reproducibility and complicate large-scale deployment. Market Opportunities
Expansion into Regulatory Toxicology and Safety Assessment
One of the largest opportunities for MPS is its transition from an academic research tool to a qualified platform for regulatory and industrial safety assessment. Liver, cardiac, kidney, lung, immune, and barrier models have particular potential for evaluating organ-specific toxicity. FDA and NIH collaboration on New Approach Methodologies is creating a more favorable environment for validated human-based models to enter formal drug-development workflows.
Development of High-Throughput and Automated MPS Platforms
Integration with multi-well formats, automated liquid handling, high-content imaging, biosensors, and data-analysis software can substantially increase MPS throughput and reproducibility. The industry is moving beyond manually operated individual chips toward scalable platforms capable of running dozens or hundreds of tissue models simultaneously, making MPS more compatible with pharmaceutical screening workflows and increasing recurring demand for consumables.
Integration with Organoids, iPSC Technology and AI
Combining MPS with patient-derived organoids, induced pluripotent stem cells, gene editing, and artificial intelligence can enable more disease-specific and patient-specific models. Such platforms could support precision medicine, patient stratification, rare-disease research, and prediction of individual drug responses. Multi-organ MPS further creates opportunities for studying systemic pharmacology, PK/PD relationships, metabolism, and organ-to-organ interactions.
Market Challenges
Balancing Physiological Complexity with Throughput and Scalability
Increasing biological realism often requires multiple cell types, vascular interfaces, extracellular matrices, mechanical stimulation, dynamic perfusion, and real-time sensing. However, greater complexity usually increases operating difficulty, cost, variability, and assay duration. Achieving sufficient physiological relevance while maintaining reproducibility, throughput, automation, and commercial scalability remains a fundamental technical challenge.
Extensive Validation Required for Regulatory Acceptance
Regulatory interest in MPS is increasing, but formal use in decision-making requires robust evidence demonstrating reproducibility, reliability, defined applicability domains, and correlation with human clinical outcomes. Cross-laboratory studies, reference-compound testing, standardized protocols, and comparison against existing methods remain necessary before individual MPS models can achieve broad regulatory acceptance.
Fragmentation of Technologies and Commercial Platforms
The MPS market includes organ-on-chip systems, organoid-based models, engineered 3D tissues, membrane and membrane-free platforms, passive and pump-driven systems, and single- and multi-organ configurations. No single architecture has emerged as the universal industry standard. This fragmentation increases platform-selection risks for pharmaceutical companies and creates significant R&D and commercialization challenges for MPS suppliers.
Report Scope
This report studies the global Microphysiological System demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Microphysiological System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Microphysiological System that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Microphysiological System total market, 2021-2032, (USD Million)
- Global Microphysiological System total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Microphysiological System total market, key domestic companies, and share, (USD Million)
- Global Microphysiological System revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Microphysiological System total market by Type, CAGR, 2021-2032, (USD Million)
- Global Microphysiological System total market by End User, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Microphysiological System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Microphysiological System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Microphysiological System Market, Segmentation by Type:
- Liver MPS
- Lung MPS
- Cardiac MPS
- Kidney MPS
- Gastrointestinal MPS
- Neural/Brain MPS
- Other
Global Microphysiological System Market, Segmentation by System Integration:
- Single-organ MPS
- Multi-organ MPS
Global Microphysiological System Market, Segmentation by Platform Type:
- Organ-on-Chip Systems
- Organoid-based MPS
- 3D Engineered Tissue MPS
- Others
Global Microphysiological System Market, Segmentation by End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
Companies Profiled:
- Emulate
- MIMETAS
- TissUse
- CN Bio Innovations
- AIM Biotech
- AlveoliX
- Beonchip
- React4life
- InSphero
- NETRI
- SynVivo
- BiomimX
- Dynamic42
- Kirkstall
- Cherry Biotech
- Micronit
- Cellbox Labs
- REVIVO BioSystems
- MesoBioTech
- Beijing Daxiang Biotech
- AVATARGET
- Suzhou Jiyan Biopharmaceutical
- Altis Biosystems
- 28bio
- Bi/ond
- Ananda Devices
Key Questions Answered
1. How big is the global Microphysiological System market?2. What is the demand of the global Microphysiological System market?
3. What is the year over year growth of the global Microphysiological System market?
4. What is the total value of the global Microphysiological System market?
5. Who are the Major Players in the global Microphysiological System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Microphysiological System Introduction
1.2 World Microphysiological System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Microphysiological System Total Market by Region (by Headquarter Location)
1.3.1 World Microphysiological System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Microphysiological System Revenue (2021-2032)
1.3.3 China Based Company Microphysiological System Revenue (2021-2032)
1.3.4 Europe Based Company Microphysiological System Revenue (2021-2032)
1.3.5 Japan Based Company Microphysiological System Revenue (2021-2032)
1.3.6 South Korea Based Company Microphysiological System Revenue (2021-2032)
1.3.7 ASEAN Based Company Microphysiological System Revenue (2021-2032)
1.3.8 India Based Company Microphysiological System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Microphysiological System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Microphysiological System Consumption Value (2021-2032)
2.2 World Microphysiological System Consumption Value by Region
2.2.1 World Microphysiological System Consumption Value by Region (2021-2026)
2.2.2 World Microphysiological System Consumption Value Forecast by Region (2027-2032)
2.3 United States Microphysiological System Consumption Value (2021-2032)
2.4 China Microphysiological System Consumption Value (2021-2032)
2.5 Europe Microphysiological System Consumption Value (2021-2032)
2.6 Japan Microphysiological System Consumption Value (2021-2032)
2.7 South Korea Microphysiological System Consumption Value (2021-2032)
2.8 ASEAN Microphysiological System Consumption Value (2021-2032)
2.9 India Microphysiological System Consumption Value (2021-2032)
3 WORLD MICROPHYSIOLOGICAL SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World Microphysiological System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Microphysiological System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Microphysiological System in 2025
3.2.3 Global Concentration Ratios (CR8) for Microphysiological System in 2025
3.3 Microphysiological System Company Evaluation Quadrant
3.4 Microphysiological System Market: Overall Company Footprint Analysis
3.4.1 Microphysiological System Market: Region Footprint
3.4.2 Microphysiological System Market: Company Product Type Footprint
3.4.3 Microphysiological System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Microphysiological System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Microphysiological System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Microphysiological System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Microphysiological System Consumption Value Comparison
4.2.1 United States VS China: Microphysiological System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Microphysiological System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Microphysiological System Companies and Market Share, 2021-2026
4.3.1 United States Based Microphysiological System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Microphysiological System Revenue, (2021-2026)
4.4 China Based Companies Microphysiological System Revenue and Market Share, 2021-2026
4.4.1 China Based Microphysiological System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Microphysiological System Revenue, (2021-2026)
4.5 Rest of World Based Microphysiological System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Microphysiological System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Microphysiological System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Microphysiological System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Liver MPS
5.2.2 Lung MPS
5.2.3 Cardiac MPS
5.2.4 Kidney MPS
5.2.5 Gastrointestinal MPS
5.2.6 Neural/Brain MPS
5.2.7 Other
5.3 Market Segment by Type
5.3.1 World Microphysiological System Market Size by Type (2021-2026)
5.3.2 World Microphysiological System Market Size by Type (2027-2032)
5.3.3 World Microphysiological System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SYSTEM INTEGRATION
6.1 World Microphysiological System Market Size Overview by System Integration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by System Integration
6.2.1 Single-organ MPS
6.2.2 Multi-organ MPS
6.3 Market Segment by System Integration
6.3.1 World Microphysiological System Market Size by System Integration (2021-2026)
6.3.2 World Microphysiological System Market Size by System Integration (2027-2032)
6.3.3 World Microphysiological System Market Size Market Share by System Integration (2027-2032)
7 MARKET ANALYSIS BY PLATFORM TYPE
7.1 World Microphysiological System Market Size Overview by Platform Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Platform Type
7.2.1 Organ-on-Chip Systems
7.2.2 Organoid-based MPS
7.2.3 3D Engineered Tissue MPS
7.2.4 Others
7.3 Market Segment by Platform Type
7.3.1 World Microphysiological System Market Size by Platform Type (2021-2026)
7.3.2 World Microphysiological System Market Size by Platform Type (2027-2032)
7.3.3 World Microphysiological System Market Size Market Share by Platform Type (2027-2032)
8 MARKET ANALYSIS BY END USER
8.1 World Microphysiological System Market Size Overview by End User: 2021 VS 2025 VS 2032
8.2 Segment Introduction by End User
8.2.1 Pharmaceutical & Biotechnology Companies
8.2.2 Academic & Research Institutes
8.2.3 Others
8.3 Market Segment by End User
8.3.1 World Microphysiological System Market Size by End User (2021-2026)
8.3.2 World Microphysiological System Market Size by End User (2027-2032)
8.3.3 World Microphysiological System Market Size Market Share by End User (2021-2032)
9 COMPANY PROFILES
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Microphysiological System Product and Services
9.1.4 Emulate Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 MIMETAS
9.2.1 MIMETAS Details
9.2.2 MIMETAS Major Business
9.2.3 MIMETAS Microphysiological System Product and Services
9.2.4 MIMETAS Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 MIMETAS Recent Developments/Updates
9.2.6 MIMETAS Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Microphysiological System Product and Services
9.3.4 TissUse Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 CN Bio Innovations
9.4.1 CN Bio Innovations Details
9.4.2 CN Bio Innovations Major Business
9.4.3 CN Bio Innovations Microphysiological System Product and Services
9.4.4 CN Bio Innovations Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 CN Bio Innovations Recent Developments/Updates
9.4.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.5 AIM Biotech
9.5.1 AIM Biotech Details
9.5.2 AIM Biotech Major Business
9.5.3 AIM Biotech Microphysiological System Product and Services
9.5.4 AIM Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 AIM Biotech Recent Developments/Updates
9.5.6 AIM Biotech Competitive Strengths & Weaknesses
9.6 AlveoliX
9.6.1 AlveoliX Details
9.6.2 AlveoliX Major Business
9.6.3 AlveoliX Microphysiological System Product and Services
9.6.4 AlveoliX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 AlveoliX Recent Developments/Updates
9.6.6 AlveoliX Competitive Strengths & Weaknesses
9.7 Beonchip
9.7.1 Beonchip Details
9.7.2 Beonchip Major Business
9.7.3 Beonchip Microphysiological System Product and Services
9.7.4 Beonchip Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Beonchip Recent Developments/Updates
9.7.6 Beonchip Competitive Strengths & Weaknesses
9.8 React4life
9.8.1 React4life Details
9.8.2 React4life Major Business
9.8.3 React4life Microphysiological System Product and Services
9.8.4 React4life Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 React4life Recent Developments/Updates
9.8.6 React4life Competitive Strengths & Weaknesses
9.9 InSphero
9.9.1 InSphero Details
9.9.2 InSphero Major Business
9.9.3 InSphero Microphysiological System Product and Services
9.9.4 InSphero Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 InSphero Recent Developments/Updates
9.9.6 InSphero Competitive Strengths & Weaknesses
9.10 NETRI
9.10.1 NETRI Details
9.10.2 NETRI Major Business
9.10.3 NETRI Microphysiological System Product and Services
9.10.4 NETRI Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 NETRI Recent Developments/Updates
9.10.6 NETRI Competitive Strengths & Weaknesses
9.11 SynVivo
9.11.1 SynVivo Details
9.11.2 SynVivo Major Business
9.11.3 SynVivo Microphysiological System Product and Services
9.11.4 SynVivo Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 SynVivo Recent Developments/Updates
9.11.6 SynVivo Competitive Strengths & Weaknesses
9.12 BiomimX
9.12.1 BiomimX Details
9.12.2 BiomimX Major Business
9.12.3 BiomimX Microphysiological System Product and Services
9.12.4 BiomimX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BiomimX Recent Developments/Updates
9.12.6 BiomimX Competitive Strengths & Weaknesses
9.13 Dynamic42
9.13.1 Dynamic42 Details
9.13.2 Dynamic42 Major Business
9.13.3 Dynamic42 Microphysiological System Product and Services
9.13.4 Dynamic42 Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Dynamic42 Recent Developments/Updates
9.13.6 Dynamic42 Competitive Strengths & Weaknesses
9.14 Kirkstall
9.14.1 Kirkstall Details
9.14.2 Kirkstall Major Business
9.14.3 Kirkstall Microphysiological System Product and Services
9.14.4 Kirkstall Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Kirkstall Recent Developments/Updates
9.14.6 Kirkstall Competitive Strengths & Weaknesses
9.15 Cherry Biotech
9.15.1 Cherry Biotech Details
9.15.2 Cherry Biotech Major Business
9.15.3 Cherry Biotech Microphysiological System Product and Services
9.15.4 Cherry Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Cherry Biotech Recent Developments/Updates
9.15.6 Cherry Biotech Competitive Strengths & Weaknesses
9.16 Micronit
9.16.1 Micronit Details
9.16.2 Micronit Major Business
9.16.3 Micronit Microphysiological System Product and Services
9.16.4 Micronit Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Micronit Recent Developments/Updates
9.16.6 Micronit Competitive Strengths & Weaknesses
9.17 Cellbox Labs
9.17.1 Cellbox Labs Details
9.17.2 Cellbox Labs Major Business
9.17.3 Cellbox Labs Microphysiological System Product and Services
9.17.4 Cellbox Labs Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Cellbox Labs Recent Developments/Updates
9.17.6 Cellbox Labs Competitive Strengths & Weaknesses
9.18 REVIVO BioSystems
9.18.1 REVIVO BioSystems Details
9.18.2 REVIVO BioSystems Major Business
9.18.3 REVIVO BioSystems Microphysiological System Product and Services
9.18.4 REVIVO BioSystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 REVIVO BioSystems Recent Developments/Updates
9.18.6 REVIVO BioSystems Competitive Strengths & Weaknesses
9.19 MesoBioTech
9.19.1 MesoBioTech Details
9.19.2 MesoBioTech Major Business
9.19.3 MesoBioTech Microphysiological System Product and Services
9.19.4 MesoBioTech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 MesoBioTech Recent Developments/Updates
9.19.6 MesoBioTech Competitive Strengths & Weaknesses
9.20 Beijing Daxiang Biotech
9.20.1 Beijing Daxiang Biotech Details
9.20.2 Beijing Daxiang Biotech Major Business
9.20.3 Beijing Daxiang Biotech Microphysiological System Product and Services
9.20.4 Beijing Daxiang Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Beijing Daxiang Biotech Recent Developments/Updates
9.20.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
9.21 AVATARGET
9.21.1 AVATARGET Details
9.21.2 AVATARGET Major Business
9.21.3 AVATARGET Microphysiological System Product and Services
9.21.4 AVATARGET Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 AVATARGET Recent Developments/Updates
9.21.6 AVATARGET Competitive Strengths & Weaknesses
9.22 Suzhou Jiyan Biopharmaceutical
9.22.1 Suzhou Jiyan Biopharmaceutical Details
9.22.2 Suzhou Jiyan Biopharmaceutical Major Business
9.22.3 Suzhou Jiyan Biopharmaceutical Microphysiological System Product and Services
9.22.4 Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
9.22.6 Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
9.23 Altis Biosystems
9.23.1 Altis Biosystems Details
9.23.2 Altis Biosystems Major Business
9.23.3 Altis Biosystems Microphysiological System Product and Services
9.23.4 Altis Biosystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Altis Biosystems Recent Developments/Updates
9.23.6 Altis Biosystems Competitive Strengths & Weaknesses
9.24 28bio
9.24.1 28bio Details
9.24.2 28bio Major Business
9.24.3 28bio Microphysiological System Product and Services
9.24.4 28bio Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 28bio Recent Developments/Updates
9.24.6 28bio Competitive Strengths & Weaknesses
9.25 Bi/ond
9.25.1 Bi/ond Details
9.25.2 Bi/ond Major Business
9.25.3 Bi/ond Microphysiological System Product and Services
9.25.4 Bi/ond Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Bi/ond Recent Developments/Updates
9.25.6 Bi/ond Competitive Strengths & Weaknesses
9.26 Ananda Devices
9.26.1 Ananda Devices Details
9.26.2 Ananda Devices Major Business
9.26.3 Ananda Devices Microphysiological System Product and Services
9.26.4 Ananda Devices Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Ananda Devices Recent Developments/Updates
9.26.6 Ananda Devices Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Microphysiological System Industry Chain
10.2 Microphysiological System Upstream Analysis
10.3 Microphysiological System Midstream Analysis
10.4 Microphysiological System Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Microphysiological System Introduction
1.2 World Microphysiological System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Microphysiological System Total Market by Region (by Headquarter Location)
1.3.1 World Microphysiological System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Microphysiological System Revenue (2021-2032)
1.3.3 China Based Company Microphysiological System Revenue (2021-2032)
1.3.4 Europe Based Company Microphysiological System Revenue (2021-2032)
1.3.5 Japan Based Company Microphysiological System Revenue (2021-2032)
1.3.6 South Korea Based Company Microphysiological System Revenue (2021-2032)
1.3.7 ASEAN Based Company Microphysiological System Revenue (2021-2032)
1.3.8 India Based Company Microphysiological System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Microphysiological System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Microphysiological System Consumption Value (2021-2032)
2.2 World Microphysiological System Consumption Value by Region
2.2.1 World Microphysiological System Consumption Value by Region (2021-2026)
2.2.2 World Microphysiological System Consumption Value Forecast by Region (2027-2032)
2.3 United States Microphysiological System Consumption Value (2021-2032)
2.4 China Microphysiological System Consumption Value (2021-2032)
2.5 Europe Microphysiological System Consumption Value (2021-2032)
2.6 Japan Microphysiological System Consumption Value (2021-2032)
2.7 South Korea Microphysiological System Consumption Value (2021-2032)
2.8 ASEAN Microphysiological System Consumption Value (2021-2032)
2.9 India Microphysiological System Consumption Value (2021-2032)
3 WORLD MICROPHYSIOLOGICAL SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World Microphysiological System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Microphysiological System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Microphysiological System in 2025
3.2.3 Global Concentration Ratios (CR8) for Microphysiological System in 2025
3.3 Microphysiological System Company Evaluation Quadrant
3.4 Microphysiological System Market: Overall Company Footprint Analysis
3.4.1 Microphysiological System Market: Region Footprint
3.4.2 Microphysiological System Market: Company Product Type Footprint
3.4.3 Microphysiological System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Microphysiological System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Microphysiological System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Microphysiological System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Microphysiological System Consumption Value Comparison
4.2.1 United States VS China: Microphysiological System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Microphysiological System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Microphysiological System Companies and Market Share, 2021-2026
4.3.1 United States Based Microphysiological System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Microphysiological System Revenue, (2021-2026)
4.4 China Based Companies Microphysiological System Revenue and Market Share, 2021-2026
4.4.1 China Based Microphysiological System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Microphysiological System Revenue, (2021-2026)
4.5 Rest of World Based Microphysiological System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Microphysiological System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Microphysiological System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Microphysiological System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Liver MPS
5.2.2 Lung MPS
5.2.3 Cardiac MPS
5.2.4 Kidney MPS
5.2.5 Gastrointestinal MPS
5.2.6 Neural/Brain MPS
5.2.7 Other
5.3 Market Segment by Type
5.3.1 World Microphysiological System Market Size by Type (2021-2026)
5.3.2 World Microphysiological System Market Size by Type (2027-2032)
5.3.3 World Microphysiological System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SYSTEM INTEGRATION
6.1 World Microphysiological System Market Size Overview by System Integration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by System Integration
6.2.1 Single-organ MPS
6.2.2 Multi-organ MPS
6.3 Market Segment by System Integration
6.3.1 World Microphysiological System Market Size by System Integration (2021-2026)
6.3.2 World Microphysiological System Market Size by System Integration (2027-2032)
6.3.3 World Microphysiological System Market Size Market Share by System Integration (2027-2032)
7 MARKET ANALYSIS BY PLATFORM TYPE
7.1 World Microphysiological System Market Size Overview by Platform Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Platform Type
7.2.1 Organ-on-Chip Systems
7.2.2 Organoid-based MPS
7.2.3 3D Engineered Tissue MPS
7.2.4 Others
7.3 Market Segment by Platform Type
7.3.1 World Microphysiological System Market Size by Platform Type (2021-2026)
7.3.2 World Microphysiological System Market Size by Platform Type (2027-2032)
7.3.3 World Microphysiological System Market Size Market Share by Platform Type (2027-2032)
8 MARKET ANALYSIS BY END USER
8.1 World Microphysiological System Market Size Overview by End User: 2021 VS 2025 VS 2032
8.2 Segment Introduction by End User
8.2.1 Pharmaceutical & Biotechnology Companies
8.2.2 Academic & Research Institutes
8.2.3 Others
8.3 Market Segment by End User
8.3.1 World Microphysiological System Market Size by End User (2021-2026)
8.3.2 World Microphysiological System Market Size by End User (2027-2032)
8.3.3 World Microphysiological System Market Size Market Share by End User (2021-2032)
9 COMPANY PROFILES
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Microphysiological System Product and Services
9.1.4 Emulate Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 MIMETAS
9.2.1 MIMETAS Details
9.2.2 MIMETAS Major Business
9.2.3 MIMETAS Microphysiological System Product and Services
9.2.4 MIMETAS Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 MIMETAS Recent Developments/Updates
9.2.6 MIMETAS Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Microphysiological System Product and Services
9.3.4 TissUse Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 CN Bio Innovations
9.4.1 CN Bio Innovations Details
9.4.2 CN Bio Innovations Major Business
9.4.3 CN Bio Innovations Microphysiological System Product and Services
9.4.4 CN Bio Innovations Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 CN Bio Innovations Recent Developments/Updates
9.4.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.5 AIM Biotech
9.5.1 AIM Biotech Details
9.5.2 AIM Biotech Major Business
9.5.3 AIM Biotech Microphysiological System Product and Services
9.5.4 AIM Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 AIM Biotech Recent Developments/Updates
9.5.6 AIM Biotech Competitive Strengths & Weaknesses
9.6 AlveoliX
9.6.1 AlveoliX Details
9.6.2 AlveoliX Major Business
9.6.3 AlveoliX Microphysiological System Product and Services
9.6.4 AlveoliX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 AlveoliX Recent Developments/Updates
9.6.6 AlveoliX Competitive Strengths & Weaknesses
9.7 Beonchip
9.7.1 Beonchip Details
9.7.2 Beonchip Major Business
9.7.3 Beonchip Microphysiological System Product and Services
9.7.4 Beonchip Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Beonchip Recent Developments/Updates
9.7.6 Beonchip Competitive Strengths & Weaknesses
9.8 React4life
9.8.1 React4life Details
9.8.2 React4life Major Business
9.8.3 React4life Microphysiological System Product and Services
9.8.4 React4life Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 React4life Recent Developments/Updates
9.8.6 React4life Competitive Strengths & Weaknesses
9.9 InSphero
9.9.1 InSphero Details
9.9.2 InSphero Major Business
9.9.3 InSphero Microphysiological System Product and Services
9.9.4 InSphero Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 InSphero Recent Developments/Updates
9.9.6 InSphero Competitive Strengths & Weaknesses
9.10 NETRI
9.10.1 NETRI Details
9.10.2 NETRI Major Business
9.10.3 NETRI Microphysiological System Product and Services
9.10.4 NETRI Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 NETRI Recent Developments/Updates
9.10.6 NETRI Competitive Strengths & Weaknesses
9.11 SynVivo
9.11.1 SynVivo Details
9.11.2 SynVivo Major Business
9.11.3 SynVivo Microphysiological System Product and Services
9.11.4 SynVivo Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 SynVivo Recent Developments/Updates
9.11.6 SynVivo Competitive Strengths & Weaknesses
9.12 BiomimX
9.12.1 BiomimX Details
9.12.2 BiomimX Major Business
9.12.3 BiomimX Microphysiological System Product and Services
9.12.4 BiomimX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BiomimX Recent Developments/Updates
9.12.6 BiomimX Competitive Strengths & Weaknesses
9.13 Dynamic42
9.13.1 Dynamic42 Details
9.13.2 Dynamic42 Major Business
9.13.3 Dynamic42 Microphysiological System Product and Services
9.13.4 Dynamic42 Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Dynamic42 Recent Developments/Updates
9.13.6 Dynamic42 Competitive Strengths & Weaknesses
9.14 Kirkstall
9.14.1 Kirkstall Details
9.14.2 Kirkstall Major Business
9.14.3 Kirkstall Microphysiological System Product and Services
9.14.4 Kirkstall Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Kirkstall Recent Developments/Updates
9.14.6 Kirkstall Competitive Strengths & Weaknesses
9.15 Cherry Biotech
9.15.1 Cherry Biotech Details
9.15.2 Cherry Biotech Major Business
9.15.3 Cherry Biotech Microphysiological System Product and Services
9.15.4 Cherry Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Cherry Biotech Recent Developments/Updates
9.15.6 Cherry Biotech Competitive Strengths & Weaknesses
9.16 Micronit
9.16.1 Micronit Details
9.16.2 Micronit Major Business
9.16.3 Micronit Microphysiological System Product and Services
9.16.4 Micronit Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Micronit Recent Developments/Updates
9.16.6 Micronit Competitive Strengths & Weaknesses
9.17 Cellbox Labs
9.17.1 Cellbox Labs Details
9.17.2 Cellbox Labs Major Business
9.17.3 Cellbox Labs Microphysiological System Product and Services
9.17.4 Cellbox Labs Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Cellbox Labs Recent Developments/Updates
9.17.6 Cellbox Labs Competitive Strengths & Weaknesses
9.18 REVIVO BioSystems
9.18.1 REVIVO BioSystems Details
9.18.2 REVIVO BioSystems Major Business
9.18.3 REVIVO BioSystems Microphysiological System Product and Services
9.18.4 REVIVO BioSystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 REVIVO BioSystems Recent Developments/Updates
9.18.6 REVIVO BioSystems Competitive Strengths & Weaknesses
9.19 MesoBioTech
9.19.1 MesoBioTech Details
9.19.2 MesoBioTech Major Business
9.19.3 MesoBioTech Microphysiological System Product and Services
9.19.4 MesoBioTech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 MesoBioTech Recent Developments/Updates
9.19.6 MesoBioTech Competitive Strengths & Weaknesses
9.20 Beijing Daxiang Biotech
9.20.1 Beijing Daxiang Biotech Details
9.20.2 Beijing Daxiang Biotech Major Business
9.20.3 Beijing Daxiang Biotech Microphysiological System Product and Services
9.20.4 Beijing Daxiang Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Beijing Daxiang Biotech Recent Developments/Updates
9.20.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
9.21 AVATARGET
9.21.1 AVATARGET Details
9.21.2 AVATARGET Major Business
9.21.3 AVATARGET Microphysiological System Product and Services
9.21.4 AVATARGET Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 AVATARGET Recent Developments/Updates
9.21.6 AVATARGET Competitive Strengths & Weaknesses
9.22 Suzhou Jiyan Biopharmaceutical
9.22.1 Suzhou Jiyan Biopharmaceutical Details
9.22.2 Suzhou Jiyan Biopharmaceutical Major Business
9.22.3 Suzhou Jiyan Biopharmaceutical Microphysiological System Product and Services
9.22.4 Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
9.22.6 Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
9.23 Altis Biosystems
9.23.1 Altis Biosystems Details
9.23.2 Altis Biosystems Major Business
9.23.3 Altis Biosystems Microphysiological System Product and Services
9.23.4 Altis Biosystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Altis Biosystems Recent Developments/Updates
9.23.6 Altis Biosystems Competitive Strengths & Weaknesses
9.24 28bio
9.24.1 28bio Details
9.24.2 28bio Major Business
9.24.3 28bio Microphysiological System Product and Services
9.24.4 28bio Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 28bio Recent Developments/Updates
9.24.6 28bio Competitive Strengths & Weaknesses
9.25 Bi/ond
9.25.1 Bi/ond Details
9.25.2 Bi/ond Major Business
9.25.3 Bi/ond Microphysiological System Product and Services
9.25.4 Bi/ond Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Bi/ond Recent Developments/Updates
9.25.6 Bi/ond Competitive Strengths & Weaknesses
9.26 Ananda Devices
9.26.1 Ananda Devices Details
9.26.2 Ananda Devices Major Business
9.26.3 Ananda Devices Microphysiological System Product and Services
9.26.4 Ananda Devices Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Ananda Devices Recent Developments/Updates
9.26.6 Ananda Devices Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Microphysiological System Industry Chain
10.2 Microphysiological System Upstream Analysis
10.3 Microphysiological System Midstream Analysis
10.4 Microphysiological System Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Microphysiological System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Microphysiological System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Microphysiological System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Microphysiological System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Microphysiological System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Microphysiological System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Microphysiological System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Microphysiological System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Microphysiological System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Microphysiological System Players in 2025
Table 12. World Microphysiological System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Microphysiological System Company Evaluation Quadrant
Table 14. Head Office of Key Microphysiological System Players
Table 15. Microphysiological System Market: Company Product Type Footprint
Table 16. Microphysiological System Market: Company Product Application Footprint
Table 17. Microphysiological System Mergers & Acquisitions Activity
Table 18. United States VS China Microphysiological System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Microphysiological System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Microphysiological System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Microphysiological System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Microphysiological System Revenue Market Share (2021-2026)
Table 23. China Based Microphysiological System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Microphysiological System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Microphysiological System Revenue Market Share (2021-2026)
Table 26. Rest of World Based Microphysiological System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Microphysiological System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Microphysiological System Revenue Market Share (2021-2026)
Table 29. World Microphysiological System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Microphysiological System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Microphysiological System Market Size by Type (2027-2032) & (USD Million)
Table 32. World Microphysiological System Market Size by System Integration, (USD Million), 2021 & 2025 & 2032
Table 33. World Microphysiological System Market Size Value by System Integration (2021-2026) & (USD Million)
Table 34. World Microphysiological System Market Size by System Integration (2027-2032) & (USD Million)
Table 35. World Microphysiological System Market Size by Platform Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Microphysiological System Market Size Value by Platform Type (2021-2026) & (USD Million)
Table 37. World Microphysiological System Market Size by Platform Type (2027-2032) & (USD Million)
Table 38. World Microphysiological System Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 39. World Microphysiological System Market Size by End User (2021-2026) & (USD Million)
Table 40. World Microphysiological System Market Size by End User (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Microphysiological System Product and Services
Table 44. Emulate Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. MIMETAS Basic Information, Manufacturing Base and Competitors
Table 48. MIMETAS Major Business
Table 49. MIMETAS Microphysiological System Product and Services
Table 50. MIMETAS Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. MIMETAS Recent Developments/Updates
Table 52. MIMETAS Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Microphysiological System Product and Services
Table 56. TissUse Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 60. CN Bio Innovations Major Business
Table 61. CN Bio Innovations Microphysiological System Product and Services
Table 62. CN Bio Innovations Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CN Bio Innovations Recent Developments/Updates
Table 64. CN Bio Innovations Competitive Strengths & Weaknesses
Table 65. AIM Biotech Basic Information, Manufacturing Base and Competitors
Table 66. AIM Biotech Major Business
Table 67. AIM Biotech Microphysiological System Product and Services
Table 68. AIM Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. AIM Biotech Recent Developments/Updates
Table 70. AIM Biotech Competitive Strengths & Weaknesses
Table 71. AlveoliX Basic Information, Manufacturing Base and Competitors
Table 72. AlveoliX Major Business
Table 73. AlveoliX Microphysiological System Product and Services
Table 74. AlveoliX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. AlveoliX Recent Developments/Updates
Table 76. AlveoliX Competitive Strengths & Weaknesses
Table 77. Beonchip Basic Information, Manufacturing Base and Competitors
Table 78. Beonchip Major Business
Table 79. Beonchip Microphysiological System Product and Services
Table 80. Beonchip Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Beonchip Recent Developments/Updates
Table 82. Beonchip Competitive Strengths & Weaknesses
Table 83. React4life Basic Information, Manufacturing Base and Competitors
Table 84. React4life Major Business
Table 85. React4life Microphysiological System Product and Services
Table 86. React4life Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. React4life Recent Developments/Updates
Table 88. React4life Competitive Strengths & Weaknesses
Table 89. InSphero Basic Information, Manufacturing Base and Competitors
Table 90. InSphero Major Business
Table 91. InSphero Microphysiological System Product and Services
Table 92. InSphero Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. InSphero Recent Developments/Updates
Table 94. InSphero Competitive Strengths & Weaknesses
Table 95. NETRI Basic Information, Manufacturing Base and Competitors
Table 96. NETRI Major Business
Table 97. NETRI Microphysiological System Product and Services
Table 98. NETRI Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. NETRI Recent Developments/Updates
Table 100. NETRI Competitive Strengths & Weaknesses
Table 101. SynVivo Basic Information, Manufacturing Base and Competitors
Table 102. SynVivo Major Business
Table 103. SynVivo Microphysiological System Product and Services
Table 104. SynVivo Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. SynVivo Recent Developments/Updates
Table 106. SynVivo Competitive Strengths & Weaknesses
Table 107. BiomimX Basic Information, Manufacturing Base and Competitors
Table 108. BiomimX Major Business
Table 109. BiomimX Microphysiological System Product and Services
Table 110. BiomimX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BiomimX Recent Developments/Updates
Table 112. BiomimX Competitive Strengths & Weaknesses
Table 113. Dynamic42 Basic Information, Manufacturing Base and Competitors
Table 114. Dynamic42 Major Business
Table 115. Dynamic42 Microphysiological System Product and Services
Table 116. Dynamic42 Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Dynamic42 Recent Developments/Updates
Table 118. Dynamic42 Competitive Strengths & Weaknesses
Table 119. Kirkstall Basic Information, Manufacturing Base and Competitors
Table 120. Kirkstall Major Business
Table 121. Kirkstall Microphysiological System Product and Services
Table 122. Kirkstall Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Kirkstall Recent Developments/Updates
Table 124. Kirkstall Competitive Strengths & Weaknesses
Table 125. Cherry Biotech Basic Information, Manufacturing Base and Competitors
Table 126. Cherry Biotech Major Business
Table 127. Cherry Biotech Microphysiological System Product and Services
Table 128. Cherry Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Cherry Biotech Recent Developments/Updates
Table 130. Cherry Biotech Competitive Strengths & Weaknesses
Table 131. Micronit Basic Information, Manufacturing Base and Competitors
Table 132. Micronit Major Business
Table 133. Micronit Microphysiological System Product and Services
Table 134. Micronit Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Micronit Recent Developments/Updates
Table 136. Micronit Competitive Strengths & Weaknesses
Table 137. Cellbox Labs Basic Information, Manufacturing Base and Competitors
Table 138. Cellbox Labs Major Business
Table 139. Cellbox Labs Microphysiological System Product and Services
Table 140. Cellbox Labs Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Cellbox Labs Recent Developments/Updates
Table 142. Cellbox Labs Competitive Strengths & Weaknesses
Table 143. REVIVO BioSystems Basic Information, Manufacturing Base and Competitors
Table 144. REVIVO BioSystems Major Business
Table 145. REVIVO BioSystems Microphysiological System Product and Services
Table 146. REVIVO BioSystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. REVIVO BioSystems Recent Developments/Updates
Table 148. REVIVO BioSystems Competitive Strengths & Weaknesses
Table 149. MesoBioTech Basic Information, Manufacturing Base and Competitors
Table 150. MesoBioTech Major Business
Table 151. MesoBioTech Microphysiological System Product and Services
Table 152. MesoBioTech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. MesoBioTech Recent Developments/Updates
Table 154. MesoBioTech Competitive Strengths & Weaknesses
Table 155. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 156. Beijing Daxiang Biotech Major Business
Table 157. Beijing Daxiang Biotech Microphysiological System Product and Services
Table 158. Beijing Daxiang Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Beijing Daxiang Biotech Recent Developments/Updates
Table 160. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 161. AVATARGET Basic Information, Manufacturing Base and Competitors
Table 162. AVATARGET Major Business
Table 163. AVATARGET Microphysiological System Product and Services
Table 164. AVATARGET Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. AVATARGET Recent Developments/Updates
Table 166. AVATARGET Competitive Strengths & Weaknesses
Table 167. Suzhou Jiyan Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 168. Suzhou Jiyan Biopharmaceutical Major Business
Table 169. Suzhou Jiyan Biopharmaceutical Microphysiological System Product and Services
Table 170. Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
Table 172. Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
Table 173. Altis Biosystems Basic Information, Manufacturing Base and Competitors
Table 174. Altis Biosystems Major Business
Table 175. Altis Biosystems Microphysiological System Product and Services
Table 176. Altis Biosystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Altis Biosystems Recent Developments/Updates
Table 178. Altis Biosystems Competitive Strengths & Weaknesses
Table 179. 28bio Basic Information, Manufacturing Base and Competitors
Table 180. 28bio Major Business
Table 181. 28bio Microphysiological System Product and Services
Table 182. 28bio Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. 28bio Recent Developments/Updates
Table 184. 28bio Competitive Strengths & Weaknesses
Table 185. Bi/ond Basic Information, Manufacturing Base and Competitors
Table 186. Bi/ond Major Business
Table 187. Bi/ond Microphysiological System Product and Services
Table 188. Bi/ond Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Bi/ond Recent Developments/Updates
Table 190. Bi/ond Competitive Strengths & Weaknesses
Table 191. Ananda Devices Basic Information, Manufacturing Base and Competitors
Table 192. Ananda Devices Major Business
Table 193. Ananda Devices Microphysiological System Product and Services
Table 194. Ananda Devices Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Ananda Devices Recent Developments/Updates
Table 196. Ananda Devices Competitive Strengths & Weaknesses
Table 197. Global Key Players of Microphysiological System Upstream (Raw Materials)
Table 198. Global Microphysiological System Typical Customers
Table 1. World Microphysiological System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Microphysiological System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Microphysiological System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Microphysiological System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Microphysiological System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Microphysiological System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Microphysiological System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Microphysiological System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Microphysiological System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Microphysiological System Players in 2025
Table 12. World Microphysiological System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Microphysiological System Company Evaluation Quadrant
Table 14. Head Office of Key Microphysiological System Players
Table 15. Microphysiological System Market: Company Product Type Footprint
Table 16. Microphysiological System Market: Company Product Application Footprint
Table 17. Microphysiological System Mergers & Acquisitions Activity
Table 18. United States VS China Microphysiological System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Microphysiological System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Microphysiological System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Microphysiological System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Microphysiological System Revenue Market Share (2021-2026)
Table 23. China Based Microphysiological System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Microphysiological System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Microphysiological System Revenue Market Share (2021-2026)
Table 26. Rest of World Based Microphysiological System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Microphysiological System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Microphysiological System Revenue Market Share (2021-2026)
Table 29. World Microphysiological System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Microphysiological System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Microphysiological System Market Size by Type (2027-2032) & (USD Million)
Table 32. World Microphysiological System Market Size by System Integration, (USD Million), 2021 & 2025 & 2032
Table 33. World Microphysiological System Market Size Value by System Integration (2021-2026) & (USD Million)
Table 34. World Microphysiological System Market Size by System Integration (2027-2032) & (USD Million)
Table 35. World Microphysiological System Market Size by Platform Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Microphysiological System Market Size Value by Platform Type (2021-2026) & (USD Million)
Table 37. World Microphysiological System Market Size by Platform Type (2027-2032) & (USD Million)
Table 38. World Microphysiological System Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 39. World Microphysiological System Market Size by End User (2021-2026) & (USD Million)
Table 40. World Microphysiological System Market Size by End User (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Microphysiological System Product and Services
Table 44. Emulate Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. MIMETAS Basic Information, Manufacturing Base and Competitors
Table 48. MIMETAS Major Business
Table 49. MIMETAS Microphysiological System Product and Services
Table 50. MIMETAS Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. MIMETAS Recent Developments/Updates
Table 52. MIMETAS Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Microphysiological System Product and Services
Table 56. TissUse Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 60. CN Bio Innovations Major Business
Table 61. CN Bio Innovations Microphysiological System Product and Services
Table 62. CN Bio Innovations Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CN Bio Innovations Recent Developments/Updates
Table 64. CN Bio Innovations Competitive Strengths & Weaknesses
Table 65. AIM Biotech Basic Information, Manufacturing Base and Competitors
Table 66. AIM Biotech Major Business
Table 67. AIM Biotech Microphysiological System Product and Services
Table 68. AIM Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. AIM Biotech Recent Developments/Updates
Table 70. AIM Biotech Competitive Strengths & Weaknesses
Table 71. AlveoliX Basic Information, Manufacturing Base and Competitors
Table 72. AlveoliX Major Business
Table 73. AlveoliX Microphysiological System Product and Services
Table 74. AlveoliX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. AlveoliX Recent Developments/Updates
Table 76. AlveoliX Competitive Strengths & Weaknesses
Table 77. Beonchip Basic Information, Manufacturing Base and Competitors
Table 78. Beonchip Major Business
Table 79. Beonchip Microphysiological System Product and Services
Table 80. Beonchip Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Beonchip Recent Developments/Updates
Table 82. Beonchip Competitive Strengths & Weaknesses
Table 83. React4life Basic Information, Manufacturing Base and Competitors
Table 84. React4life Major Business
Table 85. React4life Microphysiological System Product and Services
Table 86. React4life Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. React4life Recent Developments/Updates
Table 88. React4life Competitive Strengths & Weaknesses
Table 89. InSphero Basic Information, Manufacturing Base and Competitors
Table 90. InSphero Major Business
Table 91. InSphero Microphysiological System Product and Services
Table 92. InSphero Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. InSphero Recent Developments/Updates
Table 94. InSphero Competitive Strengths & Weaknesses
Table 95. NETRI Basic Information, Manufacturing Base and Competitors
Table 96. NETRI Major Business
Table 97. NETRI Microphysiological System Product and Services
Table 98. NETRI Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. NETRI Recent Developments/Updates
Table 100. NETRI Competitive Strengths & Weaknesses
Table 101. SynVivo Basic Information, Manufacturing Base and Competitors
Table 102. SynVivo Major Business
Table 103. SynVivo Microphysiological System Product and Services
Table 104. SynVivo Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. SynVivo Recent Developments/Updates
Table 106. SynVivo Competitive Strengths & Weaknesses
Table 107. BiomimX Basic Information, Manufacturing Base and Competitors
Table 108. BiomimX Major Business
Table 109. BiomimX Microphysiological System Product and Services
Table 110. BiomimX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BiomimX Recent Developments/Updates
Table 112. BiomimX Competitive Strengths & Weaknesses
Table 113. Dynamic42 Basic Information, Manufacturing Base and Competitors
Table 114. Dynamic42 Major Business
Table 115. Dynamic42 Microphysiological System Product and Services
Table 116. Dynamic42 Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Dynamic42 Recent Developments/Updates
Table 118. Dynamic42 Competitive Strengths & Weaknesses
Table 119. Kirkstall Basic Information, Manufacturing Base and Competitors
Table 120. Kirkstall Major Business
Table 121. Kirkstall Microphysiological System Product and Services
Table 122. Kirkstall Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Kirkstall Recent Developments/Updates
Table 124. Kirkstall Competitive Strengths & Weaknesses
Table 125. Cherry Biotech Basic Information, Manufacturing Base and Competitors
Table 126. Cherry Biotech Major Business
Table 127. Cherry Biotech Microphysiological System Product and Services
Table 128. Cherry Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Cherry Biotech Recent Developments/Updates
Table 130. Cherry Biotech Competitive Strengths & Weaknesses
Table 131. Micronit Basic Information, Manufacturing Base and Competitors
Table 132. Micronit Major Business
Table 133. Micronit Microphysiological System Product and Services
Table 134. Micronit Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Micronit Recent Developments/Updates
Table 136. Micronit Competitive Strengths & Weaknesses
Table 137. Cellbox Labs Basic Information, Manufacturing Base and Competitors
Table 138. Cellbox Labs Major Business
Table 139. Cellbox Labs Microphysiological System Product and Services
Table 140. Cellbox Labs Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Cellbox Labs Recent Developments/Updates
Table 142. Cellbox Labs Competitive Strengths & Weaknesses
Table 143. REVIVO BioSystems Basic Information, Manufacturing Base and Competitors
Table 144. REVIVO BioSystems Major Business
Table 145. REVIVO BioSystems Microphysiological System Product and Services
Table 146. REVIVO BioSystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. REVIVO BioSystems Recent Developments/Updates
Table 148. REVIVO BioSystems Competitive Strengths & Weaknesses
Table 149. MesoBioTech Basic Information, Manufacturing Base and Competitors
Table 150. MesoBioTech Major Business
Table 151. MesoBioTech Microphysiological System Product and Services
Table 152. MesoBioTech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. MesoBioTech Recent Developments/Updates
Table 154. MesoBioTech Competitive Strengths & Weaknesses
Table 155. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 156. Beijing Daxiang Biotech Major Business
Table 157. Beijing Daxiang Biotech Microphysiological System Product and Services
Table 158. Beijing Daxiang Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Beijing Daxiang Biotech Recent Developments/Updates
Table 160. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 161. AVATARGET Basic Information, Manufacturing Base and Competitors
Table 162. AVATARGET Major Business
Table 163. AVATARGET Microphysiological System Product and Services
Table 164. AVATARGET Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. AVATARGET Recent Developments/Updates
Table 166. AVATARGET Competitive Strengths & Weaknesses
Table 167. Suzhou Jiyan Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 168. Suzhou Jiyan Biopharmaceutical Major Business
Table 169. Suzhou Jiyan Biopharmaceutical Microphysiological System Product and Services
Table 170. Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
Table 172. Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
Table 173. Altis Biosystems Basic Information, Manufacturing Base and Competitors
Table 174. Altis Biosystems Major Business
Table 175. Altis Biosystems Microphysiological System Product and Services
Table 176. Altis Biosystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Altis Biosystems Recent Developments/Updates
Table 178. Altis Biosystems Competitive Strengths & Weaknesses
Table 179. 28bio Basic Information, Manufacturing Base and Competitors
Table 180. 28bio Major Business
Table 181. 28bio Microphysiological System Product and Services
Table 182. 28bio Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. 28bio Recent Developments/Updates
Table 184. 28bio Competitive Strengths & Weaknesses
Table 185. Bi/ond Basic Information, Manufacturing Base and Competitors
Table 186. Bi/ond Major Business
Table 187. Bi/ond Microphysiological System Product and Services
Table 188. Bi/ond Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Bi/ond Recent Developments/Updates
Table 190. Bi/ond Competitive Strengths & Weaknesses
Table 191. Ananda Devices Basic Information, Manufacturing Base and Competitors
Table 192. Ananda Devices Major Business
Table 193. Ananda Devices Microphysiological System Product and Services
Table 194. Ananda Devices Microphysiological System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Ananda Devices Recent Developments/Updates
Table 196. Ananda Devices Competitive Strengths & Weaknesses
Table 197. Global Key Players of Microphysiological System Upstream (Raw Materials)
Table 198. Global Microphysiological System Typical Customers
LIST OF FIGURES
Figure 1. Microphysiological System Picture
Figure 2. World Microphysiological System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Microphysiological System Total Revenue (2021-2032) & (USD Million)
Figure 4. World Microphysiological System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Microphysiological System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 13. Microphysiological System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 16. World Microphysiological System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 18. China Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 23. India Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Microphysiological System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Microphysiological System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Microphysiological System Markets in 2025
Figure 27. United States VS China: Microphysiological System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Microphysiological System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Microphysiological System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Microphysiological System Market Size Market Share by Type in 2025
Figure 31. Liver MPS
Figure 32. Lung MPS
Figure 33. Cardiac MPS
Figure 34. Kidney MPS
Figure 35. Gastrointestinal MPS
Figure 36. Neural/Brain MPS
Figure 37. Other
Figure 38. Other
Figure 39. World Microphysiological System Market Size Market Share by Type (2021-2032)
Figure 40. World Microphysiological System Market Size by System Integration, (USD Million), 2021 & 2025 & 2032
Figure 41. World Microphysiological System Market Size Market Share by System Integration in 2025
Figure 42. Single-organ MPS
Figure 43. Multi-organ MPS
Figure 44. World Microphysiological System Market Size Market Share by System Integration (2021-2032)
Figure 45. World Microphysiological System Market Size by Platform Type, (USD Million), 2021 & 2025 & 2032
Figure 46. World Microphysiological System Market Size Market Share by Platform Type in 2025
Figure 47. Organ-on-Chip Systems
Figure 48. Organoid-based MPS
Figure 49. 3D Engineered Tissue MPS
Figure 50. Others
Figure 51. World Microphysiological System Market Size Market Share by Platform Type (2021-2032)
Figure 52. World Microphysiological System Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 53. World Microphysiological System Market Size Market Share by End User in 2025
Figure 54. Pharmaceutical & Biotechnology Companies
Figure 55. Academic & Research Institutes
Figure 56. Others
Figure 57. World Microphysiological System Market Size Market Share by End User (2021-2032)
Figure 58. Microphysiological System Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. Microphysiological System Picture
Figure 2. World Microphysiological System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Microphysiological System Total Revenue (2021-2032) & (USD Million)
Figure 4. World Microphysiological System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Microphysiological System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Microphysiological System Revenue (2021-2032) & (USD Million)
Figure 13. Microphysiological System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 16. World Microphysiological System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 18. China Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 23. India Microphysiological System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Microphysiological System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Microphysiological System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Microphysiological System Markets in 2025
Figure 27. United States VS China: Microphysiological System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Microphysiological System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Microphysiological System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Microphysiological System Market Size Market Share by Type in 2025
Figure 31. Liver MPS
Figure 32. Lung MPS
Figure 33. Cardiac MPS
Figure 34. Kidney MPS
Figure 35. Gastrointestinal MPS
Figure 36. Neural/Brain MPS
Figure 37. Other
Figure 38. Other
Figure 39. World Microphysiological System Market Size Market Share by Type (2021-2032)
Figure 40. World Microphysiological System Market Size by System Integration, (USD Million), 2021 & 2025 & 2032
Figure 41. World Microphysiological System Market Size Market Share by System Integration in 2025
Figure 42. Single-organ MPS
Figure 43. Multi-organ MPS
Figure 44. World Microphysiological System Market Size Market Share by System Integration (2021-2032)
Figure 45. World Microphysiological System Market Size by Platform Type, (USD Million), 2021 & 2025 & 2032
Figure 46. World Microphysiological System Market Size Market Share by Platform Type in 2025
Figure 47. Organ-on-Chip Systems
Figure 48. Organoid-based MPS
Figure 49. 3D Engineered Tissue MPS
Figure 50. Others
Figure 51. World Microphysiological System Market Size Market Share by Platform Type (2021-2032)
Figure 52. World Microphysiological System Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 53. World Microphysiological System Market Size Market Share by End User in 2025
Figure 54. Pharmaceutical & Biotechnology Companies
Figure 55. Academic & Research Institutes
Figure 56. Others
Figure 57. World Microphysiological System Market Size Market Share by End User (2021-2032)
Figure 58. Microphysiological System Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
